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Abstract
Feedlyve AGL is a feed additive that is available in liquid and solid formulations and contains endo-1,3
(4)-b-glucanase, which is produced by a strain of Aspergillus niger. The tolerance trial submitted did
not comply with the requirements of tolerance trials, and consequently, the study was considered not
valid. Therefore, the EFSA Panel on Additives and Products or Substances used in Animal Feed
(FEEDAP) could not conclude on the safety of the additive for the target species. The enzyme
concentrate gave negative results in a bacterial reverse mutation assay and in an in vitro chromosome
aberration assay. Moreover, the substance was negative in an in vivo micronucleus test in the rat bone
marrow and the results of the subchronic oral toxicity study showed no adverse effects. However, the
correspondence of the test item used and the fermentation product that is currently used to prepare
the additive was not established. Therefore, the FEEDAP Panel was not in a position to conclude on
the safety for the consumer of the additive. The tests conducted in order to address the safety for the
user indicated that the test items were not toxic by inhalation, not irritant to the eyes or skin but
showed a dermal sensitisation potential. However, the relationship between the test items and the
additive for which re-evaluation is sought were not fully established. The additive is considered as a
potential respiratory sensitizer. No risks to the environment are expected. The results of two efﬁcacy
trials showed that 100 AGL U/kg feed increased the apparent metabolisable energy of the diets in one
trial and improved the body weight gain and the gain to feed ratio in another trial. However, a third
trial showing signiﬁcant and positive effects would be required to positively conclude on the efﬁcacy of
the product.
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Summary
Following a request from the European Commission, the Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on the safety and
efﬁcacy of Feedlyve AGL as a feed additive for chickens for fattening. This additive is authorised for
use as a feed additive in chickens for fattening and the applicant requested for the re-evaluation of the
product. Feedlyve AGL is a preparation of endo-1,3(4)-b-glucanase (glucanase) that is available in
liquid and solid formulations. The enzyme that is contained in the additive is produced by a strain of
Aspergillus niger. However, the identity of the strain was not conﬁrmed by molecular techniques.
One tolerance trial in chickens for fattening was evaluated. The animals were under study from day
7 to day 21 of life. This duration was not in accordance with the requirements for tolerance trials in
terms of age at start and duration of the treatment (start on day 1 of life and study for 35 days).
Moreover, the study lacked replicates, and therefore, the statistical evaluation of the data would not be
possible. The Panel considered this study as not valid and could not conclude on the safety of the
additive for the target species.
The enzyme concentrate gave negative results in a bacterial reverse mutation assay and in an
in vitro chromosome aberration assay. Moreover, the substance was negative in an in vivo
micronucleus test in the rat bone marrow, although no evidence of target cell exposure was provided.
The results of a subchronic oral toxicity study showed no adverse effects. These tests were conducted
in the 1990s, with the exception of the in vivo micronucleus test, which was performed in 2010.
The correspondence of the test item with the fermentation product that is currently used to formulate
the additive was not established. Therefore, the FEEDAP Panel was not in a position to conclude on
the safety for the consumer of the additive.
An acute inhalation study, the skin and eye irritation tests and a skin sensitisation study were
performed and indicated that the test items were not toxic by inhalation and not irritant to the eyes or
skin but had a dermal sensitisation potential. However, the relationship between the test items and the
additive for which re-evaluation is sought were not fully established. Owing to the proteinaceous
nature of the active substance, the additive is considered as a potential respiratory sensitiser.
The active substance of the additive is a protein and as such will be degraded/inactivated during
the passage through the digestive tract of animals. Therefore, no risks to the environment are
expected and no further environmental risk assessment is required.
Five efﬁcacy trials, three short-term and two long-term, were submitted. Two of the short-term
trials were not considered further due to the nature of the parameters measured. One of the long-
term trials was not considered further due to several limitations in the methodologies followed and
reporting that were not addressed/explained by the applicant. The results of the other two trials
showed that the addition of 100 AGL U/kg feed to the diets increased the apparent metabolisable
energy of the diets in one trial and improved the body weight gain and the gain to feed ratio in
another trial. However, another trial showing signiﬁcant and positive effects would be required to
positively conclude on the efﬁcacy of the product.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 10(2) of that Regulation also speciﬁes that for
existing products within the meaning of Article 10(1), an application shall be submitted in accordance
with Article 7, at the latest one year before the expiry date of the authorisation given pursuant to
Directive 70/524/EEC for additives with a limited authorisation period, and within a maximum of
7 years after the entry into force of this Regulation for additives authorised without a time limit or
pursuant to Directive 82/471/EEC.
The European Commission received a request from LYVEN2 for re-evaluation of the authorisation of
the product Feedlyve AGL (endo-1,3(4)-b-glucanase), when used as a feed additive for chickens for
fattening (category: zootechnical additive; functional group: digestibility enhancers).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 10(2)
(re-evaluation of an authorised feed additive). EFSA received directly from the applicant the technical
dossier in support of this application. The particulars and documents in support of the application were
considered valid by EFSA as of 16 April 2015.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment, and on the efﬁcacy of the
product Feedlyve AGL (endo-1,3(4)-b-glucanase), when used under the proposed conditions of use
(see Section 3.1.4).
1.2. Additional information
The additive Feedlyve® AGL is a preparation of endo-1,3(4)-b-glucanase (EC 3.2.1.6) produced by
a strain of Aspergillus niger (MUCL 39199). This product is authorised in the European Union (EU) as a
feed additive for chickens for fattening.3 The Scientiﬁc Committee on Animal Nutrition issued an
opinion on the safety of use of this additive for the target species (chickens for fattening), consumers
and users (EC, 2002).
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier4 in support of the authorisation request for the use of Feedlyve AGL as a feed additive. The
technical dossier was prepared following the provisions of Article 7 of Regulation (EC) No 1831/2003,
Regulation (EC) No 429/20085 and the applicable EFSA guidance documents.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the Feedlyve AGL in animal feed. The Executive Summary of the EURL
report can be found in Annex A.6
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 LYVEN ZAC Normandial, 11 Avenue du Pays de Caen, 14460 Colombelles, France.
3 Commission Regulation (EC) No 1458/2005 of 8 September 2005 concerning the permanent and provisional authorisations of
certain additives in feedingstuffs and the provisional authorisation of new uses of certain additives already authorised in
feedingstuffs. OJ L 233, 9.9.2005, p. 3–7.
4 FEED dossier reference: FAD-2010-0227.
5 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
6 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/ﬁles/ﬁnirep-fad-2010-0227-feedlyve_
agl.pdf
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2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of Feedlyve AGL
is in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant guidance
documents: Guidance on zootechnical additives (EFSA FEEDAP Panel, 2012a), Technical guidance:
Tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011), Technical Guidance for
assessing the safety of feed additives for the environment (EFSA, 2008), Guidance for establishing the
safety of additives for the consumer (EFSA FEEDAP Panel, 2012b) and Guidance on studies concerning
the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012c).
3. Assessment
This opinion deals with the re-evaluation of the safety and efﬁcacy of FEEDLYVE AGL (endo-1,3(4)-
b-glucanase, (EC 3.2.1.6; glucanase)) as a feed additive for chickens for fattening.
3.1. Characterisation of the active substance
The main activity of the additive is glucanase but other side activities are present (non-starch
polysaccharidases). The glucanase is obtained by fermentation with a strain of Aspergillus niger
deposited in 1995 at the Mycotheque de l’Universite Catholique de Louvain with the accession number
(MUCL 39199). No evidence was provided that the strain is still deposited in the culture collection.7
The identiﬁcation of the strain was carried out by morphological examination,8 but no conﬁrmation of
the identity was provided using molecular techniques. Characteristics of the growth of the strain and
ability to produce glucanase were provided along with the genomic ﬁngerprinting of the strain.9
However, the identiﬁcation was not conﬁrmed using molecular techniques. This strain is a mutant as
stated in the certiﬁcate of deposition, but no details on the methodologies and steps followed to select
the strain were provided in order to support the statement. The genetic stability of the strain was not
studied and no data on the potential of the production strain to produce potentially toxic secondary
metabolites was provided.
3.1.1. Manufacturing process10
The enzyme is obtained by a multi-step process consisting of fermentation, concentration and
puriﬁcation steps. The product obtained is stabilised. The liquid formulations are obtained from this
product by addition of the carriers/stabilisers. For the preparation of the solid formulations, the
stabilised liquid is spray-dried. The product obtained is used to prepare the solid formulations (referred
to as Feedlyve AGL BRUTE (CNS)). Indications on the enzyme activity at the different points of the
manufacturing were provided, expressed per initial dry matter in the fermenter.
The dossier contains information on the spray-dried product used to prepare the solid formulations,
Feedlyve AGL BRUTE (CNS). The batch-to-batch variation in the enzyme activity in ﬁve batches
showed mean values of 12,627 AGL U/g (range: 12,012–14,030).11,12
3.1.2. Characterisation of the additive
The additive is available in two solid (Feedlyve AGL 1500 P and 6000 P) and two liquid forms
(Feedlyve AGL 200 L and 1500 L). Another formulation, Feedlyve AGL 400 P, was mentioned in the
dossier but the information provided does not allow a full characterisation.
Feedlyve AGL 1500 P and 6000 P are solid formulations standardised to ensure 1,500 or
6,000 AGL U/g, respectively. The study of the batch-to-batch variation in ﬁve batches showed a mean
value of 1,777 AGL U/g (range 1,560–2,154, with a coefﬁcient of variation (CV) of 14%) for Feedlyve
AGL 1500 P and a mean value of 6,912 AGL U/g (range 6,345–8,000; CV of 10%) for Feedlyve AGL
6000 P.13 These formulations contain Feedlyve AGL BRUTE (CNS), 0.5% tricalcium phosphate and
7 Technical dossier/Section II/Annex II.2.1.B.
8 Technical dossier/Section II/Annex II.2.1.C and II.2.1.D.
9 Technical dossier/Section II/Annex II.2.1.E–2.1.G and Annex II.2.1.Fbis.
10 This section has been amended following the conﬁdentiality claims made by the applicant.
11 AGL U is the amount of enzyme which liberates 5.55 lmol of reducing sugars (glucose equivalents) from barley b-glucan per
minute at pH 4.8 and 30°C.
12 Technical dossier/Section II/Annex II.1.3.B.
13 Technical dossier/Section II/Annex II.1.3.A.
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wheat ﬂour. Data on the physicochemical properties of the two solid formulations were submitted,
including pH, density, particle size distribution and dusting potential.14 The study of the particle size
(by sieving) in three batches of each formulation was provided and the particles < 40 lm ranged from
53 to 58% for Feedlyve AGL 1500 P and 34–68% for Feedlyve AGL 6000 P, but the data did not
include information on particle size distribution below 40 lm. The dusting potential was measured in
one batch for each formulation and was 0.1 mg/50 g for the 1500 P formulation and 2.3 mg/50 g
product for the 6000 P.
Feedlyve AGL 200 L and 1500 L are the liquid formulations standardised to ensure 200 or 1500 AGL
U/g, respectively. The study of the batch-to-batch variation in three batches showed a mean value of
245 AGL U/g (range: 230–262) for Feedlyve AGL 200 L and a mean value in ﬁve batches of 1,612 AGL
U/g (range: 1,516–1,742; CV of 6%) for Feedlyve AGL 1500 L.15 These formulations contain the liquid
product obtained after fermentation, 30% sorbitol, 5% monopotassium phosphate, 0.02% potassium
sorbate and water.16 The pH of these formulations is 5 and the density is 1.16–1.18 kg/m3.17
The purity of the ﬁnal formulations was not provided; however, data on one batch of the
fermentation product (liquid) was made available for chemical and microbial purity.18 Chemical analysis
included lead (0.06 mg/kg), arsenic (< 0.10 mg/kg), cadmium (< 0.05 mg/kg) and mercury
(< 0.03 mg/kg). Mycotoxins including aﬂatoxins (< 0.1 lg/kg), zearalenone (6.0 lg/kg) and ochratoxin
(0.5 lg/kg) were also analysed in these batches. Microbial analysis was done for total viable counts
(< 1,000 colony-forming units (CFU)/g), Salmonella spp. (absent in 25 g), coliforms, Escherichia coli
(< 1 CFU/g), anaerobic sulfate reducers (< 10 CFU/g) and Staphylococcus aureus (absent in 1 g). The
test on the presence of antibiotic activity revealed no evidence of such activity. The same information
(including also the absence of the production strain) was provided for three batches of Feedlyve AGL
BRUTE (CNS),19 batches from 1993 to 1995, but the correspondence of the batches analysed with the
product that is currently used to manufacture the additive has not been established.
3.1.3. Stability and homogeneity
3.1.3.1. Shelf life
Three batches of the liquid (200 L and 1,500 L) and solid formulations (1500 P and 6000 P) were
kept at three different temperatures (4, 20 and 30°C) in closed packages for 3 months (liquid) or for
12 months (solid).20 The enzyme recoveries (in %) were calculated as the activity present in the test
sample compared to the activity present in a frozen sample at the same time point. Recoveries were
> 95% after 3 months in all situations studied. The test also included the study of the effect of light (by
comparing samples in darkness and the effect of open or closed packages), air and humidity, this last test
was done only in the solid formulations.21 These factors had no impact on the shelf life of the enzyme.
The data provided showed the following limitations: the claimed shelf life (2 years) was not studied
in any of the tests, the initial enzyme activity of the batches was not provided and the recoveries were
calculated comparing the enzyme activity to a frozen sample, which could have also lost activity.
3.1.3.2. Stability and homogeneity of the additive
The stability of three batches of the two solid formulations (1500 P and 6000 P) added to a
vitamin/mineral premixture (without choline chloride), enzyme activity of 25 U/g, was studied. Samples
of the premixture were stored at 4, 20 and 30°C for up to 4 months.22 After 4 months, mean enzyme
activity was > 95% in all cases (expressed as compared to a frozen sample). No data were provided
on the stability in premixtures up to 6 months of storage.
The stability of the additive (unknown formulation) was studied when added to a complete
compound feed and then pelleted at 75, 78 or 80°C.23 Recoveries were < 33%, indicating low stability
of the enzyme to heat treatment. The stability of three batches of the liquid (200 L and 1,500 L) and
14 Technical dossier/Section II/Annexes II.1.5.B and II.1.5.C.
15 Technical dossier/Section II/Annex II.1.3.A and II.1.5.B.
16 Technical dossier/Section II/Annex II.1.3.
17 Technical dossier/Section II/Annex II.1.5.B.
18 Technical dossier/Section II/Annex II.2.1.J.
19 Technical dossier/Section II/Annex II.1.4.A–1.4.E.
20 Technical dossier/Section II/Annex II.4.1.A.
21 Technical dossier/Section II/Annex II.4.1.B and II.4.1.C and Annex II.4.1.D.
22 Technical dossier/Section II/Annex II.4.1.E and Annex II.4.1.J.
23 Technical dossier/Section II/Annex II.4.1.H and Annex II.4.1.F.
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solid formulations (1500 P and 6000 P) added to a complete feed (mash form for solid and pelleted for
liquid) at an enzyme activity of 100 AGL U/kg feed was studied. Samples of the feed were stored at 4,
20 and 30°C for up to 3 months.24 Mean recovery values were > 94% (expressed as compared to a
frozen sample).
The premixture and mash feed used for the stability studies were sampled ﬁve times (less than the
required 10 subsamples) in order to study the capacity of the additive to distribute homogeneously.25
Samples in premixtures showed a CV < 6%, and samples in feed showed CV of 6% for Feedlyve AGL
1500 P and < 12% for the Feedlyve AGL 200 L.
3.1.4. Conditions of use
The additive is to be used in chickens for fattening at a minimum dose of 25 AGL U/kg feed and a
maximum dose of 100 AGL U/kg feed up to 35 days.
3.2. Safety
3.2.1. Safety for the target species
The applicant submitted one trial in chickens for fattening26 to support the safety for the target
species.26 However, this study is considered not acceptable since the animals were under study from
day 7 to day 21 of life and there were no replicates. Therefore, the Panel cannot conclude on the
safety of the additive for the target species.
3.2.2. Safety for the consumer
The applicant submitted a bacterial reverse mutation assay (OECD TG 471),27 an in vitro
chromosome aberration assay (OECD TG 473),28 an in vivo micronucleus test (OECD TG 474)29 and a
subchronic oral toxicity study (OECD TG 408).30
The test item used for these studies was Feedlyve AGL BRUTE (CNS) which was claimed to be the
non-standardised spray-dried fermentation product with dextrin and monopotassium phosphate used
in the formulation of the solid formulations. The tests items used in these tests were manufactured in
the 1990s with the exception of the one used in the in vivo micronucleus test, that was from 2010.
The correspondence of those test items and the fermentation product that is currently used to
formulate the additive was not established.
The results obtained in the studies submitted do not indicate any reason for concern for consumer
safety arising from the use of the additive as a feed additive. However, since the correspondence of
the test item and the fermentation product that is currently used has not been established, the
FEEDAP Panel is not in a position to conclude on the safety for the consumer of the additive.
3.2.3. Safety for the user
An acute inhalation study (OECD TG 403),31 the skin (OECD TG 404) and eye (OECD TG 405)
irritation studies32 and a skin sensitisation study (OECD TG 406)33 were submitted. Feedlyve AGL
BRUTE (CNS) was the test item in the acute inhalation study and in the skin sensitisation study, and a
test item identiﬁed as ‘Glucanase 6400’ was used in the skin and eye irritation studies.
The test materials were not toxic by inhalation and not irritant to the skin and eyes but showed
a moderate dermal sensitising potential. However, their correspondence with the product for which
re-evaluation is sought was not established; therefore, the FEEDAP Panel is not in the position to
conclude on these properties. Owing to the proteinaceous nature of the active substance, the additive
is considered as a potential respiratory sensitiser.
24 Technical dossier/Section II/Annex II.4.1.K and Annex II.4.1.F.
25 Technical dossier/Section II/Annexes II.4.2.A–4.2.C.
26 Technical dossier/Section III/Annex III.1.A.
27 Technical dossier/Section III/Annex III.2.2.B.
28 Technical dossier/Section III/Annex III.2.2.C.
29 Technical dossier/Section III/Annex III.2.2.H.
30 Technical dossier/Section III/Annex III.2.2.D–2.2.G.
31 Technical dossier/Section III/Annex III.2.2.A.
32 Technical dossier/Section III/Annex III.3.1.B and Annex III.3.1.A.
33 Technical dossier/Section III/Annex III.3.1.C.
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3.2.4. Safety for the environment
The active substance of the additive is a protein and as such will be degraded/inactivated during
the passage through the digestive tract of animals. Therefore, no risks to the environment are
expected and no further environmental risk assessment is required.
3.3. Efﬁcacy for chickens for fattening
Five trials, three short-term and two long-term, were submitted. Two of the short-term trials were
not considered further due to the nature of the parameters measured.34 One of the long-term trials
was not considered further due to several limitations in the methodologies followed35 and reporting36
that were not addressed/explained by the applicant.
In the short-term trial considered,37 a total of thirty-six 14-day-old male chickens for fattening were
distributed in groups of three birds to two dietary treatments (representing six replicates per
treatment). A basal diet based on barley and soya bean meal was either not supplemented (control) or
supplemented with Feedlyve AGL 1500 P to provide 100 AGL U/kg feed. The enzyme activity was
conﬁrmed by analysis. The diets were offered to the birds for 7 days in mash form and contained
titanium dioxide as an external marker. On day 21 of life, samples of the excreta were collected and
analysed for gross energy, nitrogen and the marker. The apparent metabolisable energy corrected for
nitrogen of the diets was calculated. An analysis of variance was performed with the data and the
comparison of the mean values of the two treatments was done with a t-test; the statistical
signiﬁcance level was set at p < 0.05. Results showed that the apparent metabolisable energy
(nitrogen corrected) contained in the diets supplemented with the enzyme was signiﬁcantly higher
than in the non-supplemented one (from 10.54 to 11.63 MJ/kg feed).
In the long-term trial,38 a total of 360 one-day-old male chickens for fattening (Cobb) were
grouped in pens of 30 birds and allocated to two dietary treatments (representing six replicates per
treatment). Basal diets (starter and grower) based on barley and soy were either not supplemented
(control) or supplemented with Feedlyve AGL 1500 P in order to provide 100 AGL U/kg feed. The
enzyme activity was conﬁrmed by analysis. Feed was offered on ad libitum basis and in mash form to
the birds. Health status of the birds and mortality were checked throughout the study. Birds were
weighed and feed intake was measured in a pen basis. Feed to gain ratio was calculated. An analysis
of variance was performed with the data; the statistical signiﬁcance level was set at p < 0.05. Seven
birds died during the experiment, four from the control diet and three from the 100 AGL U/kg feed
diet. No differences were found between the dietary treatments on the feed intake (4.3 kg per bird).
Compared to the control, the supplemented diet signiﬁcantly increased the body weight gain of the
birds (2.0 vs 2.2 kg) and improved the gain to feed ratio (0.47 vs 0.52).
The dose of 25 AGL U/kg feed was not tested in any of the two trials considered. The results
showed that the addition of 100 AGL U/kg feed (maximum dose) to the diets permitted to have a
higher apparent metabolisable energy of the diets in one trial and a higher body weight gain and
better gain to feed ratio in another trial. However, another trial showing signiﬁcant and positive effects
would be required to positively conclude on the efﬁcacy of the product.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation39 and Good Manufacturing
Practice.
4. Conclusions
Owing to the lack of data/information, the FEEDAP Panel is not in the position to conclude on the
identity of the production strain, the safety of the additive for the target species, consumer or on the
34 Technical dossier/Section IV/Annex IV.2.B and IV.2.C.
35 Including redistribution of birds after day 12 under study due to a high mortality registered after ﬂooding.
36 Discrepancies found in the information regarding the animals and their distribution, data reported per period but not in the
overall, missing data regarding the distribution of the birds after ﬂooding and analytical results of the enzyme activity missing.
37 Technical dossier/Section IV/Annex IV.2.A.
38 Technical dossier/Section IV/Annex IV.3.A.
39 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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dermal/eye irritancy potential and the dermal sensitisation properties of the additive. The additive is to
be considered a potential respiratory sensitiser. The use of Feedlyve AGL as a feed additive poses no
risks to the environment.
The Panel cannot conclude on the efﬁcacy of Feedlyve AGL as a feed additive for chickens for
fattening.
Documentation provided to EFSA
1) Feedlyve AGL for chickens for fattening. November 2010. Submitted by LYVEN.
2) Evaluation report of the European Union Reference Laboratory for Feed Additives on the
Methods(s) of Analysis for Feedlyve AGL.
3) Comments from Member States.
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Methods of Analysis
for Feedlyve AGL
Feedlyve® AGL is currently authorised as feed additive for chickens for fattening by Commission
Regulation (EC) No 1458/2005. In the current application authorisation is sought under article 10 (2)
of Regulation (EC) No 1831/2003 under the category/functional group “zootechnical additives”/
“digestibility enhancers” for chickens for fattening.
According to the Applicant, Feedlyve® AGL contains endo-1,3(4)-b-glucanase as active agent. The
Applicant expresses the glucanase enzymatic activity in glucanase units (AGL), deﬁned as “1 AGL, the
amount of enzyme which liberates 5.55 lmol of reducing sugars (glucose equivalents) from barley
beta-glucan per minute at pH 4.8 and 30°C”. The product is intended to be marketed as solid and
liquid formulations having a guaranteed minimum glucanase activity ranging from 200 to 6000 AGL/g
of product. The feed additive formulations are intended to be included through premixtures or directly
in feedingstuffs to obtain a minimum activity of 25 AGL/kg feedingstuffs. However the Applicant
proposed a recommended dose ranging from 25 to 100 AGL/kg feedingstuffs.
For the quantiﬁcation of the glucanase activity in the feed additive and feedingstuffs the Applicant
submitted a single-laboratory validated and further veriﬁed colorimetric method based on the
enzymatic hydrolysis of barley beta-glucan at pH 4.8 and 30°C, and the quantiﬁcation of dyed
oligomers released from the substrate Remazol-Brilliant-Blue-R glucan. Furthermore, the Applicant
applied this method successfully for the quantiﬁcation of glucanase in premixtures, in the frame of the
stability studies. Based on the satisfactory performance characteristics available, the EURL
recommends for ofﬁcial control of this colorimetric method for the quantiﬁcation of the glucanase
activity in the feed additive, premixtures and feedingstuffs.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
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